Danaher Corporation (DHR) - Total Assets
Based on the latest financial reports, Danaher Corporation (DHR) holds total assets worth $79.90 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Danaher Corporation net assets for net asset value and shareholders' equity analysis.
Danaher Corporation - Total Assets Trend (1985–2024)
This chart illustrates how Danaher Corporation's total assets have evolved over time, based on quarterly financial data.
Danaher Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
Danaher Corporation's total assets of $79.90 Billion consist of 12.3% current assets and 87.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $2.08 Billion | 2.7% |
| Accounts Receivable | $4.39 Billion | 5.7% |
| Inventory | $2.33 Billion | 3.0% |
| Property, Plant & Equipment | $6.07 Billion | 7.8% |
| Intangible Assets | $18.57 Billion | 24.0% |
| Goodwill | $40.50 Billion | 52.2% |
Asset Composition Trend (1985–2024)
This chart illustrates how Danaher Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Danaher Corporation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Danaher Corporation's current assets represent 12.3% of total assets in 2024, a decrease from 65.6% in 1985.
- Cash Position: Cash and equivalents constituted 2.7% of total assets in 2024, down from 35.2% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 75.0% of total assets, an increase from 8.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 52.2% of total assets.
Danaher Corporation Competitors by Total Assets
Key competitors of Danaher Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Danaher Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.52 | 1.37 | 1.86 |
| Quick Ratio | 1.10 | 1.01 | 1.55 |
| Cash Ratio | 0.24 | 0.36 | 0.00 |
| Working Capital | $3.28 Billion | $2.72 Billion | $6.40 Billion |
Danaher Corporation - Advanced Valuation Insights
This section examines the relationship between Danaher Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.25 |
| Latest Market Cap to Assets Ratio | 1.60 |
| Asset Growth Rate (YoY) | -8.2% |
| Total Assets | $77.54 Billion |
| Market Capitalization | $123.72 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Danaher Corporation's assets above their book value (1.60x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Danaher Corporation's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Danaher Corporation (1985–2024)
The table below shows the annual total assets of Danaher Corporation from 1985 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $77.54 Billion | -8.22% |
| 2023-12-31 | $84.49 Billion | +0.16% |
| 2022-12-31 | $84.35 Billion | +1.40% |
| 2021-12-31 | $83.18 Billion | +9.22% |
| 2020-12-31 | $76.16 Billion | +22.68% |
| 2019-12-31 | $62.08 Billion | +29.79% |
| 2018-12-31 | $47.83 Billion | +2.54% |
| 2017-12-31 | $46.65 Billion | +2.99% |
| 2016-12-31 | $45.30 Billion | -6.07% |
| 2015-12-31 | $48.22 Billion | +30.36% |
| 2014-12-31 | $36.99 Billion | +6.69% |
| 2013-12-31 | $34.67 Billion | +5.26% |
| 2012-12-31 | $32.94 Billion | +9.99% |
| 2011-12-31 | $29.95 Billion | +34.80% |
| 2010-12-31 | $22.22 Billion | +13.38% |
| 2009-12-31 | $19.60 Billion | +12.04% |
| 2008-12-31 | $17.49 Billion | +0.10% |
| 2007-12-31 | $17.47 Billion | +35.82% |
| 2006-12-31 | $12.86 Billion | +40.39% |
| 2005-12-31 | $9.16 Billion | +7.88% |
| 2004-12-31 | $8.49 Billion | +23.28% |
| 2003-12-31 | $6.89 Billion | +14.28% |
| 2002-12-31 | $6.03 Billion | +25.07% |
| 2001-12-31 | $4.82 Billion | +19.57% |
| 2000-12-31 | $4.03 Billion | +32.31% |
| 1999-12-31 | $3.05 Billion | +11.26% |
| 1998-12-31 | $2.74 Billion | +45.70% |
| 1997-12-31 | $1.88 Billion | +6.49% |
| 1996-12-31 | $1.77 Billion | +18.78% |
| 1995-12-31 | $1.49 Billion | +30.94% |
| 1994-12-31 | $1.13 Billion | +30.07% |
| 1993-12-31 | $872.50 Million | +13.34% |
| 1992-12-31 | $769.80 Million | +4.73% |
| 1991-12-31 | $735.00 Million | -1.28% |
| 1990-12-31 | $744.50 Million | +46.79% |
| 1989-12-31 | $507.20 Million | -11.91% |
| 1988-12-31 | $575.80 Million | -12.13% |
| 1987-12-31 | $655.30 Million | -11.53% |
| 1986-12-31 | $740.70 Million | +175.46% |
| 1985-12-31 | $268.90 Million | -- |
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the deve… Read more